Document is current

Article History

Received: 7 August 2024

Accepted: 22 October 2024

First Online: 26 November 2024

Declarations

:

: AH is a speaker, trainer, consultant and clinical trial investigator for Galderma. LA is a speaker, trainer, consultant and clinical trial investigator for Galderma. SGF is a consultant, investigator and speaker for Galderma, Allergan, Merz and Revance. JS is a speaker and advisor for Galderma. MSom is a speaker, trainer, clinical trial investigator, consultant for Galderma and Merz. DD’AC is a consultant, investigator and speaker for Galderma, Allergan and IBSA. MP has conducted research and/or served as an advisory board member, speaker, and/or trainer at Endo Aesthetics, BTL Industries, Allergan, Galderma, Merz Pharma, Lumenis, EltaMD, and Revision. KKD is a speaker, trainer, consultant, and investigator for Galderma. MS is a speaker and consultant for Galderma. RVB is a speaker, trainer, consultant and clinical trial investigator for Galderma. LH is a speaker, trainer, consultant for Galderma. KMB is a speaker, trainer, clinical investigator and consultant for Galderma. JH is a consultant and speaker for Galderma and a speaker for Merz. RF is a speaker, trainer and consultant for Galderma, and consultant for Allergan and Merz. DH is a speaker, consultant and researcher for Galderma and a speaker for Merz. CM is an employee of Galderma. FW is an employee of Galderma. IP is an employee of Galderma. DB is an employee of Galderma.

: This article does not contain any studies with human participants or animals performed by any of the authors.

: For this type of study, informed consent is not required.